Biopharmaceutical innovation in California’s Bay Area is bringing about new research, high-skilled talent and a collaborative ecosystem fueling the nation’s next set of scientific discoveries. At our recent event, in partnership with The Atlantic, “Innovation Pipeline: Examining Modern Medicine,” leaders from Amgen, BMS, California Life Sciences Association, UCSF and the venture capital community discuss what it means to put the bio in biotech.